Sarepta Therapeutics Inc (NASDAQ:SRPT) - Share price - Overview

Stock Report

Sarepta Therapeutics Inc SRPT

Last Price
$28.68

Day Change
0.40|1.41%

As of 21/02/2017
16:15:00 EST | USD
Minimum 15 Minutes Delay.

Last Close28.28
Day Range28.08 - 29.00
Mkt Cap1.57Bil
52-Wk Range8.00 - 63.73
Yield %-
ISINUS8036071004
Volume2,139,772
P/E-5.43
P/S1,111.11
P/CF-6.77

Share Price

Financials
201320142015
More ...
Income Statement
Revenue14.229.761.25
Operating Income-90.28-133.79-220.18
Net Income-111.99-135.79-220.03
Basic EPS-3.31-3.39-5.20
Avg. Diluted Shares Outstanding344042
Balance Sheet
Current Assets270.81247.80224.54
Non Current Assets20.7647.2449.24
Total Assets291.57295.03273.78
Current Liabilities35.9736.8762.29
Total Liabilities44.3847.3883.44
Total Equity247.19247.65190.35
Cash Flow
Operating Cash Flow-64.70-128.54-149.47
Capital Expenditure-3.78-26.83-4.83
Free Cash Flow-68.47-155.36-154.30

In millions, except "Basic EPS". Currency is USD.

Company Profile

Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of RNA-targeted therapeutics for the treatment of rare, infectious and other diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

270
Key Stats
More ...
Price/Earning TTM-5.36
Price/Book3.78
Price/Sales TTM1,043.54
Rev Growth (3 year avg)-67.74
EPS Growth (3 year avg)-
Operating Margin % TTM-17,572.55
Net Margin % TTM-17,560.26
ROE TTM-100.47
Debt/Equity0.08
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.